Veterinary Medicine Information website

Denagard Vet. oral opløsning 125 mg/ml

Authorised
  • Tiamulin hydrogen fumarate
  • Tiamulin hydrogen fumarate
  • Tiamulin hydrogen fumarate
Download as PDF

Product identification

Medicine name:
Denagard Vet. oral opløsning 125 mg/ml
Active substance:
  • Tiamulin hydrogen fumarate
  • Tiamulin hydrogen fumarate
  • Tiamulin hydrogen fumarate
Target species:
  • Poultry
  • Pig
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tiamulin hydrogen fumarate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tiamulin hydrogen fumarate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Poultry
      • Meat and offal
        36
        hour
      • Meat and offal
        36
        hour
      • Meat and offal
        36
        hour
    • Pig
      • Meat and offal
        4
        day
      • Meat and offal
        4
        day
      • Meat and offal
        4
        day
      • Eggs
        0
        day
      • Eggs
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Novartis Healthcare A/S
  • Elanco France S.A.S
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 10323
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, ORAL OPLØSNING 125 MG-ML)
Published on: 29/06/2023
Download